Subscribe To
Moderna may be facing its toughest moment ever. time to sell?
Moderna reported a billion-dollar loss in the third quarter and began downsizing its manufacturing infrastructure to match lower levels of ...
November 4, 2023, 5:00 am
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...
November 3, 2023, 8:30 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...
November 3, 2023, 8:30 pm
Moderna ceo discusses earnings and how the company aims to break even by 2026
While boasting a third-quarter revenue beat, biotech firm Moderna (MRNA) reported an overwhelmingly higher-than-expected loss of $9.53 per share. Its ...
November 2, 2023, 6:24 pm
Moderna shares slide after posting a loss on falling covid-19 vaccine sales and production
Moderna (MRNA) shares tumbled over 6% Thursday after reporting a steep loss as the drug maker lost sales and cut back on making its COVID-19 vaccine, ...
November 2, 2023, 4:55 pm
Ocugen to host conference call on thursday, november 9 at 8:30 a.m. et to discuss business updates and third quarter 2023 financial results
MALVERN, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, ...
November 2, 2023, 11:30 am
Moderna stock plummets on 3q loss and weak sales guidance
Moderna Therapeutics Inc (NASDAQ:MRNA) stock moved lower on Thursday after the drugmaker's weak full-year sales forecast and a significant loss for th...
November 2, 2023, 11:27 am
Novavax to host conference call to discuss third quarter 2023 financial results and operational highlights on november 9, 2023
GAITHERSBURG, Md. , Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™...
November 2, 2023, 9:25 am
Moderna revenue tops expectations, expects to return to sales growth in 2025
Moderna on Thursday said it expected 2023 revenue of at least $6 billion, a decline reflecting weaker demand for COVID-19 vaccines this year, but that...
November 2, 2023, 6:35 am
Hillevax to present at upcoming investor conferences
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerci...
November 1, 2023, 4:48 pm
Gsk beats on q3 earnings and sales, raises 2023 guidance
GSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The company raises guidance for earnings and sales on ...
November 1, 2023, 12:47 pm
Gsk receives a mixed city reaction despite raised outlook
GSK PLC (LSE:GSK, NYSE:GSK) has received mixed reactions from City analysts despite an objectively strong third-quarter performance and raised financi...
November 1, 2023, 12:03 pm
Gsk boosts profit forecasts after ‘outstanding' rsv vaccine launch
High demand for the vaccine pulled in around $850 million during the third quarter—reportedly double ...
November 1, 2023, 6:38 am
Unlike pfizer, moderna can meet 2023 covid forecast, analysts say
Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID ...
November 1, 2023, 6:03 am
Wework shares plunge on report of looming bankruptcy as match group stock slumps on tinder owner's israel warning
Novovax Inc. NVAX shares jumped 3% after the U.S. pharma firm's new COVID vaccine gained approval in th...
November 1, 2023, 5:34 am
Scancell melanoma trial data chosen for poster presentation at sitc
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) told investors that it has been selected for a poster presentation of data from the first stage of its Pha...
November 1, 2023, 4:16 am
Gsk raises outlook amid strong demand for new rsv vaccine
GSK PLC (LSE:GSK, NYSE:GSK) said a strong third quarter performance has driven a further upgrade to full-year guidance boosted by demand for its respi...
November 1, 2023, 3:31 am
Gsk raises annual forecasts again on strong arexvy launch
GSK raised its full-year profit and sales forecasts on Wednesday for the second time this year, betting on the strong launch of its respiratory syncyt...
November 1, 2023, 3:05 am
Pfizer quarterly results hit by soft demand for covid-19 products
Sales of the company's coronavirus vaccine Comirnaty dropped 70% during the third quarter compared with...
October 31, 2023, 8:20 pm
Gsk reports earnings wednesday. what to watch.
The company will for the first time report sales of Arexvy, its new RSV vaccine that launched this fall...
October 31, 2023, 5:00 pm